Determining the value of antimicrobial surveillance programs
- 28 December 2001
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 41 (4) , 171-175
- https://doi.org/10.1016/s0732-8893(01)00318-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Carbapenem-Resistant Klebsiella pneumoniae in Singapore Producing IMP-1 β-Lactamase and Lacking an Outer Membrane Protein Antimicrobial Agents and Chemotherapy, 2001
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview.Journal of Antimicrobial Chemotherapy, 2000
- Toward multinational antimicrobial resistance surveillance systems in EuropeInternational Journal of Antimicrobial Agents, 2000
- Surveillance of Antimicrobial Use and Antimicrobial Resistance in United States Hospitals: Project ICARE Phase 2Clinical Infectious Diseases, 1999
- Trends in the Antimicrobial Susceptibility of Bacterial Respiratory Tract Pathogens - Findings of the Alexander Project 1992-1996Journal of Chemotherapy, 1999
- Reports on Surveillance of Antimicrobial Resistance in Individual CountriesClinical Infectious Diseases, 1997
- Surveillance of Antimicrobial Resistance: The WHONET ProgramClinical Infectious Diseases, 1997
- A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander ProjectJournal of Antimicrobial Chemotherapy, 1996
- Meropenem: a microbiological overviewJournal of Antimicrobial Chemotherapy, 1995
- Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum -lactamasesJournal of Antimicrobial Chemotherapy, 1989